Expanding sources of evidence for better signal detection – New podcast out now

Research / 23 February 2023

In this digital age, can pharmacovigilance experts leverage on new types of data to find evidence for signals? Listen to the latest Drug Safety Matters podcast to find out.

Spontaneous adverse drug reaction reports have been the proverbial ‘bread and butter’ for signal detection since the beginnings of pharmacovigilance. But times are changing, and with the abundance of data now available in a society that has gone digital, so it is time to explore new data sources to detect signals.

Join Federica Santoro and Daniele Sartori, a pharmacovigilance scientist at UMC and doctoral researcher at the University of Oxford, discuss expanding sources of evidence for more reliable signal detection.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

You may also like

Fruitful start for EHDEN-powered signal discovery

In a weeklong groundbreaking study-a-thon with the IMI EHDEN consortium, UMC researchers found longitudinal health data could boost preliminary analysis of drug-event combinations.

Research / 28 October 2022

UMC science gets personal

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Research / 16 March 2023

Unmasking data in the COVID-19 vaccine era

First came the COVID-19 pandemic. Then came the COVID-19 vaccines. Then came millions of COVID-19 vaccine reports of suspected side effects. What are the implications of that?

Research / 25 November 2022

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more